The breakthrough in protein misfolding disorders [2/11/25]
Protein misfolding underlies numerous genetic disorders, including Alzheimer’s disease, Parkinson’s disease, and various others. Often, a single amino acid substitution can destabili s e a protein, disrupt its normal function, and compromise intracellular quality control systems. Consequently, correcting such misfolding errors constitutes a central objective in contemporary molecular medicine. A promising therapeutic approach involves pharmacological chaperones small molecules that bind to misfolded or unstable proteins, facilitating proper folding and restoring functional activity. Unlike broad-spectrum chemical chaperones, pharmacological chaperones exhibit specificity, frequently targeting the protein’s active site or ligand-binding domain. Recently, a significant advancement was reported in Nature Communications, where researchers identified a small-molecule compound functioning as a near-un...